[1]王刘玉,万全会,陈军.黄芪多糖对MC-3T3-E1成骨细胞增殖的影响及作用机制研究[J].中医正骨,2023,35(08):1-7.
 WANG Liuyu,WAN Quanhui,CHEN Jun.Effects and mechanism of Astragalan on proliferation of MC-3T3-E1 cells:an experimental study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2023,35(08):1-7.
点击复制

黄芪多糖对MC-3T3-E1成骨细胞增殖的影响及作用机制研究()
分享到:

《中医正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第35卷
期数:
2023年08期
页码:
1-7
栏目:
基础研究
出版日期:
2023-08-20

文章信息/Info

Title:
Effects and mechanism of Astragalan on proliferation of MC-3T3-E1 cells:an experimental study
作者:
王刘玉万全会陈军
南阳市第二人民医院,河南 南阳 473003
Author(s):
WANG LiuyuWAN QuanhuiCHEN Jun
Nanyang Second General Hospital,Nanyang 473003,Henan,China
关键词:
骨质疏松 成骨细胞 细胞增殖 黄芪多糖 信号传导
Keywords:
osteoporosis osteoblasts cell proliferation astragalan signal transduction
摘要:
目的:探讨黄芪多糖对MC-3T3-E1成骨细胞增殖的影响及作用机制。方法:将培养的第3代MC-3T3-E1成骨细胞分为黄芪多糖低、中、高浓度组及黄芪多糖联合抑制剂干预组、对照组,黄芪多糖低、中、高浓度组分别用含有0.1 mol·L-1、1.0 mol·L-1、10 mol·L-1黄芪多糖的DMEM培养基进行培养,黄芪多糖联合抑制剂干预组用含有10 mol·L-1黄芪多糖和10 μmol·L-1 Compound C的DMEM培养基进行培养,对照组用DMEM培养基进行培养。干预24 h后,检测细胞增殖活力及碱性磷酸酶(alkaline phosphatase,ALP)、骨钙素(osteocalcin,OCN)、B淋巴细胞瘤-2(B-lymphoblastoma-2,Bcl-2)、Bcl-2相关X蛋白(Bcl-2-related X protein,BAX)、半胱氨酸天冬氨酸蛋白酶(cysteine aspartic acid specific protease,Caspase)-3、磷酸化腺苷一磷酸活化蛋白激酶(phosphorylated AMP-activated protein kinase,p-AMPK)、内皮型一氧化氮合酶(endothelial nitric oxide synthase,eNOS)等基因的蛋白表达情况。结果:①MC-3T3-E1成骨细胞增殖活力检测结果。黄芪多糖中、高浓度组细胞增殖活力均大于对照组(LSD-t=6.708,P=0.000; LSD-t=8.221,P=0.000)和黄芪多糖联合抑制剂干预组(LSD-t=2.314,P=0.049; LSD-t=5.286,P=0.001),黄芪多糖高浓度组细胞增殖活力大于黄芪多糖低、中浓度组(LSD-t=5.579,P=0.001; LSD-t=4.423,P=0.010)。②MC-3T3-E1成骨细胞成骨标志基因蛋白表达检测结果。黄芪多糖低、中、高浓度组细胞ALP、OCN的蛋白表达量均高于对照组(ALP:LSD-t=3.528,P=0.008; LSD-t=4.417,P=0.002; LSD-t=6.822,P=0.000; OCN:LSD-t=3.153,P=0.014; LSD-t=6.485,P=0.000; LSD-t=6.543,P=0.000)和黄芪多糖联合抑制剂干预组(ALP:LSD-t=2.414,P=0.042; LSD-t=3.155,P=0.013; LSD-t=5.892,P=0.000; OCN:LSD-t=2.339,P=0.047; LSD-t=5.926,P=0.000; LSD-t=14.546,P=0.000),黄芪多糖高浓度组细胞ALP、OCN的蛋白表达量高于黄芪多糖低、中浓度组(ALP:LSD-t=3.727,P=0.006; LSD-t=3.702,P=0.006; OCN:LSD-t=4.737,P=0.001; LSD-t=2.625,P=0.031)。③MC-3T3-E1成骨细胞线粒体凋亡途径相关基因蛋白表达检测结果。黄芪多糖中、高浓度组细胞Bcl-2的蛋白表达量均高于对照组(LSD-t=5.238,P=0.001; LSD-t=9.618,P=0.000)和黄芪多糖联合抑制剂干预组(LSD-t=3.821,P=0.006; LSD-t=8.246,P=0.000),黄芪多糖高浓度组细胞Bcl-2的蛋白表达量高于黄芪多糖低、中浓度组(LSD-t=8.875,P=0.001; LSD-t=6.102,P=0.000); 黄芪多糖中、高浓度组细胞BAX、Caspase-3的蛋白表达量均低于对照组(BAX:LSD-t=5.285,P=0.001; LSD-t=7.340,P=0.000; Caspase-3:LSD-t=3.654,P=0.006; LSD-t=6.875,P=0.000)和黄芪多糖联合抑制剂干预组(BAX:LSD-t=3.654,P=0.006; LSD-t=6.875,P=0.000; Caspase-3:LSD-t=2.940,P=0.019; LSD-t=6.314,P=0.000),黄芪多糖高浓度组细胞BAX、Caspase-3的蛋白表达量均低于黄芪多糖低、中浓度组(BAX:LSD-t=7.442,P=0.001; LSD-t=3.690,P=0.006; Caspase-3:LSD-t=4.496,P=0.002; LSD-t=4.642,P=0.002)。④MC-3T3-E1成骨细胞AMPK/eNOS信号通路相关基因蛋白表达检测结果。黄芪多糖低、中、高浓度组细胞p-AMPK、eNOS的蛋白表达量均高于对照组(p-AMPK:LSD-t=3.082,P=0.015; LSD-t=4.546,P=0.002; LSD-t=5.064,P=0.001; eNOS:LSD-t=3.395,P=0.009; LSD-t=5.873,P=0.000; LSD-t=7.327,P=0.000)和黄芪多糖联合抑制剂干预组(p-AMPK:LSD-t=5.819,P=0.000; LSD-t=6.731,P=0.000; LSD-t=6.961,P=0.000; eNOS:LSD-t=4.851,P=0.001; LSD-t=7.761,P=0.000; LSD-t=8.200,P=0.000)。黄芪多糖高浓度组细胞p-AMPK、eNOS的蛋白表达量高于黄芪多糖低浓度组(LSD-t=3.200,P=0.013; LSD-t=4.985,P=0.001)。结论:黄芪多糖能够促进MC-3T3-E1成骨细胞增殖,且该作用具有一定的浓度依赖性,其作用机制可能与调控线粒体凋亡途径及AMPK/eNOS信号通路有关。
Abstract:
Objective:To investigate the effects and mechanism of Astragalan on proliferation of MC-3T3-E1 cells.Methods:The MC-3T3-E1 cells were cultured,and the third-generation cells were collected and divided into Astragalan low-concentration group,Astragalan medium-concentration group,Astragalan high-concentratione group,Astragalan combined inhibitor intervention group and control group.The MC-3T3-E1 cells in control group were cultured in normal Dulbecco's Modified Eagle's Medium(DMEM),the ones in Astragalan low-,medium- and high-concentration group were cultured in DMEM supplemented with Astragalan with concentration of 0.1,1.0 and 10 mol/L respectively,and the ones in Astragalan combined inhibitor intervention group were cultured in DMEM supplemented with Astragalan and Compound C with concentration of 10 mol/L and 10 μmol/L respectively.After 24-hour culture,the MC-3T3-E1 cells proliferation activity and the protein expression levels of alkaline phosphatase(ALP),osteocalcin(OCN),B-lymphoblastoma-2(Bcl-2),Bcl-2-related X protein(BAX),cysteine aspartic acid specific protease(Caspase)-3,phosphorylated AMP-activated protein kinase(p-AMPK)and endothelial nitric oxide synthase(eNOS)were detected.Results:①The MC-3T3-E1 cells proliferation activity was higher in Astragalan middle- and high-concentration group compared to control group(LSD-t=6.708,P=0.000; LSD-t=8.221,P=0.000)and Astragalan combined inhibitor intervention group(LSD-t=2.314,P=0.049; LSD-t=5.286,P=0.001),and was higher in Astragalan high-concentration group compared to Astragalan low- and middle-concentration group(LSD-t=5.579,P=0.001; LSD-t=4.423,P=0.010).②The protein expression levels of ALP and OCN were higher in Astragalan low-,middle- and high-concentration group compared to control group(ALP:LSD-t=3.528,P=0.008; LSD-t=4.417,P=0.002; LSD-t=6.822,P=0.000; OCN:LSD-t=3.153,P=0.014; LSD-t=6.485,P=0.000; LSD-t=6.543,P=0.000)and Astragalan combined inhibitor intervention group(ALP:LSD-t=2.414,P=0.042; LSD-t=3.155,P=0.013; LSD-t=5.892,P=0.000; OCN:LSD-t=2.339,P=0.047; LSD-t=5.926,P=0.000; LSD-t=14.546,P=0.000),and was higher in Astragalan high-concentration group compared to Astragalan low- and middle-concentration group(ALP:LSD-t=3.727,P=0.006; LSD-t=3.702,P=0.006; OCN:LSD-t=4.737,P=0.001; LSD-t=2.625,P=0.031).③The protein expression level of Bcl-2 was higher in Astragalan middle- and high-concentration group compared to control group(LSD-t=5.238,P=0.001; LSD-t=9.618,P=0.000)and Astragalan combined inhibitor intervention group(LSD-t=3.821,P=0.006; LSD-t=8.246,P=0.000),and was higher in Astragalan high-concentration group compared to Astragalan low- and middle-concentration group(LSD-t=8.875,P=0.001; LSD-t=6.102,P=0.000).The protein expression levels of BAX and Caspase-3 were lower in Astragalan middle- and high-concentration group compared to control group(BAX:LSD-t=5.285,P=0.001; LSD-t=7.340,P=0.000; Caspase-3:LSD-t=3.654,P=0.006; LSD-t=6.875,P=0.000)and Astragalan combined inhibitor intervention group(BAX:LSD-t=3.654,P=0.006; LSD-t=6.875,P=0.000; Caspase-3:LSD-t=2.940,P=0.019; LSD-t=6.314,P=0.000),and was lower in Astragalan high-concentration group compared to Astragalan low- and middle-concentration group(BAX:LSD-t=7.442,P=0.001; LSD-t=3.690,P=0.006; Caspase-3:LSD-t=4.496,P=0.002; LSD-t=4.642,P=0.002).④The protein expression levels of p-AMPK and eNOS were higher in Astragalan low-,middle- and high-concentration group compared to control group(p-AMPK:LSD-t=3.082,P=0.015; LSD-t=4.546,P=0.002; LSD-t=5.064,P=0.001; eNOS:LSD-t=3.395,P=0.009; LSD-t=5.873,P=0.000; LSD-t=7.327,P=0.000)and Astragalan combined inhibitor intervention group(p-AMPK:LSD-t=5.819,P=0.000; LSD-t=6.731,P=0.000; LSD-t=6.961,P=0.000; eNOS:LSD-t=4.851,P=0.001; LSD-t=7.761,P=0.000; LSD-t=8.200,P=0.000),and was higher in Astragalan high-concentration group compared to Astragalan low-concentration group(LSD-t=3.200,P=0.013; LSD-t=4.985,P=0.001).Conclusion:Astragalan can promote the proliferation of MC-3T3-E1 cells,which exhibits a certain concentration-dependence,and its mechanism may be related to the regulation of mitochondrial-mediated apoptosis pathway and AMPK/eNOS signaling pathway.

参考文献/References:

[1] JILKA R L,O'BRIEN C A.The role of osteocytes in age-related bone loss[J].Curr Osteoporos Rep,2016,14(1):16-25.
[2] TSAO Y T,HUANG Y J,WU H H,et al.Osteocalcin mediates biomineralization during osteogenic maturation in human mesenchymal stromal cells[J].Int J MolSci,2017,18(1):E159.
[3] 邓宇,刘奎,陈廖斌.补肾壮骨汤联合经皮椎体后凸成形术治疗老年骨质疏松性胸腰椎压缩性骨折[J].中医学报,2017,32(10):1890-1894.
[4] 李关鑫,郑金尧,冯伟利.益肾补骨汤联合椎体成形术治疗老年骨质疏松性胸腰椎压缩骨折76例[J].中医研究,2019,32(3):41-43.
[5] SHI J X,CAI X Q,ZHAO Z H,et al.Mechanism of Huangqi Sanxian Decoction inhibiting osteoclast differentiation based on network pharmacology[J].Evid Based Complement Alternat Med,2022,2022:8769531.
[6] 邓艳玲,翁文玉,招泽豪,等.黄芪三仙汤抗绝经后骨质疏松作用机制的研究[J].广州中医药大学学报,2022,39(4):898-907.
[7] 王磊,卢志伟,许小敏,等.黄芪多糖对X线辐射骨髓间充质干细胞向成骨方向分化的影响[J].中国中医药信息杂志,2017,24(12):47-51.
[8] 柴艺汇,高洁,田兴中,等.黄芪多糖对MC-3T3-E1成骨细胞CYP27B,CYP24A mRNA及蛋白表达的影响[J].中国实验方剂学杂志,2018,24(13):147-151.
[9] 柴艺汇,高洁,陈云志,等.黄芪多糖对小鼠MC-3T3-E1成骨细胞维生素D受体mRNA及蛋白表达的影响[J].时珍国医国药,2018,29(6):1281-1283.
[10] LIU T,ZHANG M,NIU H,et al.Astragalus polysaccharide from Astragalus Melittin ameliorates inflammation via suppressing the activation of TLR-4/NF-κB p65 signal pathway and protects mice from CVB3-induced virus myocarditis[J].Int J Biol Macromol,2019,126:179-186.
[11] ZHOU J,ZHANG N,ZHAO L,et al.Astragalus polysaccharides and saponins alleviate liver injury and regulate gut microbiota in alcohol liver disease mice[J].Foods,2021,10(11):2688.
中医正骨2023年8月第35卷第8期 J Trad Chin Orthop Trauma,2023,Vol.35,No.8(总567)
(总568)中医正骨2023年8月第35卷第8期 J Trad Chin Orthop Trauma,2023,Vol.35,No.8
[12] SUN Q,WU X,WANG H,et al.Protective effects of astragalus polysaccharides on oxidative stress in high glucose-induced or SOD2-silenced H9C2 cells based on PCR array analysis[J].Diabetes Metab Syndr Obes,2019,25(12):2209-2220.
[13] SUN S,YANG S,AN N,et al.Astragalus polysaccharides inhibits cardiomyocyte apoptosis during diabetic cardiomyopathy via the endoplasmic reticulum stress pathway[J].J Ethnopharmacol,2019,28(238):111857.
[14] YANG F,YAN G,LI Y,et al.Astragalus polysaccharide attenuated iron overload-induced dysfunction of mesenchymal stem cells via suppressing mitochondrial ROS[J].Cell Physiol iochem,2016,39(4):1369-1379.
[15] LI Q,XING W,GONG X,et al.Astragalus polysaccharide promotes proliferation and osteogenic differentiation of bone mesenchymal stem cells by down-regulation of microRNA-152[J].Biomed Pharmacother,2019,115:108927.
[16] XU F,REN L,SONG M,et al.Fas-and mitochondria-medi-ated signaling pathway involved in osteoblast apoptosis induced by AlCl3[J].Biol Trace Elem Res,2018,184(1):173-185.
[17] NIE Z,CHEN S,DENG S,et al.Gene expression profiling of osteoblasts subjected to dexamethasone-induced apoptosis with/without GSK3β-shRNA[J].BiochemBiophys Res Commun,2018,506(1):41-47.
[18] IGUCHI M,HIROI M,KANEGAE H,et al.Costimulation of murine osteoblasts with interferon-γ and tumor necrosis factor-α induces apoptosis through downregulation of Bcl-2 and release of cytochrome c from mitochondria[J].Mediators Inflamm,2018,2018:3979606.
[19] DENG S,NIE Z G,PENG P J,et al.Decrease of GSK3β Ser-9 phosphorylation induced osteoblast apoptosis in rat osteoarthritis model[J].Curr Med Sci,2019,39(1):75-80.
[20] PANG T,GONG M,HAN J,et al.Relationship between osteoporosis and expression of Bcl-2 and CXCL12[J].ExpTher Med,2018,15(2):1293-1297.
[21] KANAZAWA I,TAKENO A,TANAKA K I,et al.Osteoblast AMP-activated protein kinase regulates glucose metabolism and bone mass in adult mice[J].Biochem Biophys Res Commun,2018,503(3):1955-1961.
[22] KUWANA M,WATANABE H,ABE S,et al.Expression of Mn-SOD,iNOS and eNOS mRNAs in osteoblasts from the maxilla of osteopetrotic mice[J].Anat Histol Embryol,2013,42(2):124-129.
[23] 宋杰,胡阳黔,刘坚,等.黄芪多糖通过活化AMPK-eNOS信号通路减轻游离脂肪酸对人血管内皮细胞的损伤[J].中国病理生理杂志,2015,31(7):1305-1308.
[24] ZHANG R,QIN X,ZHANG T,et al.Astragalus polysaccharide improves insulin sensitivity via AMPK activation in 3T3-L1 adipocytes[J].Molecules,2018,23(10):2711.
[25] TUO X,DENG Z,HUANG G,et al.Astragalus polysaccharide attenuates overexercise-induce myocardial injury via activating AMPK signaling pathway to suppress inflammation and oxidative stress[J].An Acad Bras Cienc,2021,94(1):e20210314.

相似文献/References:

[1]李林军.应用膨胀式椎弓根螺钉内固定治疗合并骨质疏松的 胸腰椎退行性疾病[J].中医正骨,2015,27(08):49.
[2]韩艳,温利平,刘娜,等.补肾活血方对去卵巢大鼠骨代谢及骨密度的影响[J].中医正骨,2015,27(12):7.
 HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(补肾活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):7.
[3]李学朋,朱立国.骨疏康胶囊对去卵巢大鼠骨小梁的影响[J].中医正骨,2015,27(12):12.
 LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康胶囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):12.
[4]陈冠军,陈扬,庄汝杰.可灌注骨水泥椎弓根螺钉系统 在老年腰椎疾患手术中的应用[J].中医正骨,2015,27(02):40.
[5]王丹辉,贲越,韩梅.林蛙油治疗绝经后骨质疏松症的临床研究[J].中医正骨,2014,26(01):27.
 Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(08):27.
[6]黄建华,黄建武,李慧辉,等.加味左归丸对绝经后骨质疏松症肝肾不足证 患者骨密度的影响[J].中医正骨,2013,25(11):19.
 Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(08):19.
[7]项旻,杨虹,林爱菊,等.绝经后2型糖尿病患者骨质疏松与血微量元素的关系研究[J].中医正骨,2013,25(12):20.
 Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(08):20.
[8]史晓林,李春雯,张志强.弱阳离子磁珠分离技术和基质辅助激光解吸电离飞行时间质谱技术在原发性Ⅰ型骨质疏松症血清标志蛋白筛选中的应用[J].中医正骨,2014,26(03):5.
 Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(08):5.
[9]李明,徐明雄,冯左基,等.自拟壮骨方治疗绝经后骨质疏松症的疗效及作用机制研究[J].中医正骨,2014,26(09):21.
 Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(08):21.
[10]陈俊杰,李晴晴,夏瑢.脂代谢及血清内脂素水平与绝经后骨质疏松症的 相关性研究[J].中医正骨,2012,24(04):16.
 CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(08):16.

备注/Memo

备注/Memo:
通讯作者:陈军 E-mail:byjshi@163.com
更新日期/Last Update: 1900-01-01